Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTIC: Ticagrelor vs Clopidogrel in Prior MI
NCT02663713Phase 4Completed
- Sponsor
- University of Patras
- Start
- Jan 2017
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ticagrelor in myocardial infarction (MI) (2 arms), sponsored by University of Patras. Primary endpoint: Platelet reactivity measured in P2Y12 reaction units at 14 days. Started Jan 2017; status: completed.
02
Drugs
ticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02663713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663713.